New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples

Table 1 Clinical data of patients

	Fibrosis F1/F2(n= 39)	Cirrhosis F4(n= 44)	HCC(n= 34)
Age	44 ± 11	62 ± 8	67 ± 8
Gender (male/female)	29/10	22/22	25/9
ALT	57 ± 100	62 ± 43	55 ± 47
AST	28 ± 30	46 ± 30	52 ± 34
Bilirubin (mg/dL)	0.8 ± 0.5	1.2 ± 1.0	2.0 ± 4.0
Quick (%)	105 ± 7	85 ± 16	85 ± 17
AFP (μg/mL)1	3.4	6.2	39.95
Platelets (1000/μL)	214 ± 61	131 ± 62	145 ± 73
Albumin (g/dL)	4.5 ± 0.3	3.9 ± 0.6	3.5 ± 0.6
Child Pugh (A/B/C) (%)	NA	35/7/2 80/16/4	20/11/3 59/32/9
Okuda	NA	NA	18/2/4

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; AFP: Alfa-fetoprotein; NA: Not available.

¹ Median values are given.